Sectors
RNAZ
TransCode Therapeutics, Inc.
2.07
2 x 1.66
2 x 2.79
bid
ask
-
0.11
5.05%
02:06 PM
timesize
| Ytd | -69.69% | |
| 1y | -78.73% |
1.83
day range
2.28
1.83
52 week range
20.99
| Open | 2.10 | Prev Close | 2.18 | Low | 1.83 | High | 2.28 | Mkt Cap | 2.19M |
| Vol | 799.06K | Avg Vol | 69.05K | EPS | -48.28 | P/E | N/A | Forward P/E | -5.97 |
| Beta | 1.24 | Short Ratio | 0.50 | Inst. Own | 1.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.43 | 200-d Avg | 7.61 | 1yr Est | 20.00 |
| Income Statement | |||
| Operating Expenses | 6.79M | ||
| Research and Development Expense | 3.69M | ||
| Selling, General and Administrative Expense | 2.54M | ||
| Operating Income | -6.79M | ||
| Income Tax Expense | 300.00 | ||
| Net Income | -6.75M | ||
| Net Income Common Stock | -6.87M | ||
| Net Income Common Stock (USD) | -6.87M | ||
| Consolidated Income | -6.75M | ||
| Earnings per Basic Share | -7.17 | ||
| Earnings per Basic Share (USD) | -7.17 | ||
| Earnings per Diluted Share | -7.17 | ||
| Earning Before Interest & Taxes (EBIT) | -6.75M | ||
| Earning Before Interest & Taxes (USD) | -6.75M | ||
| Preferred Dividends Income Statement Impact | 115.02K | ||
| Weighted Average Shares | 957.19K | ||
| Weighted Average Shares Diluted | 957.19K | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.38M | ||
| Cash and Equivalents (USD) | 8.38M | ||
| Trade and Non-Trade Receivables | 638.00 | ||
| Current Assets | 10.64M | ||
| Property, Plant & Equipment Net | 322.81K | ||
| Total Assets | 151.01M | ||
| Debt Current | 652.41K | ||
| Total Debt | 652.41K | ||
| Current Liabilities | 5.40M | ||
| Total Liabilities | 12.65M | ||
| Accumulated Retained Earnings (Deficit) | -122.40M | ||
| Shareholders Equity | -27.69M | ||
| Shareholders Equity (USD) | -27.69M | ||
| Assets Non-Current | 140.37M | ||
| Total Debt (USD) | 652.41K | ||
| Deferred Revenue | 63.95K | ||
| Goodwill and Intangible Assets | 140.04M | ||
| Liabilities Non-Current | 7.25M | ||
| Trade and Non-Trade Payables | 4.68M | ||
| Tax Liabilities | 457.68K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 23.94K | ||
| Net Cash Flow from Financing | 950.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.45M | ||
| Issuance (Repayment) of Debt Securities | 950.00K | ||
| Net Cash Flow from Operations | -5.40M | ||